Literature DB >> 10029566

Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation.

P Mayoral1, M Criado, F Hidalgo, O Flores, M A Arévalo, N Eleno, A Sánchez-Rodríguez, J M López-Novoa, A Esteller.   

Abstract

Hepatic fibrosis or increased liver collagen contents drive functional abnormalities that, when extensive, may be life threatening. The purpose of this study was to assess the effects of the chronic stimulation or inhibition of nitric oxide synthesis in rats with hepatic fibrosis induced by permanent common bile duct ligation (3 weeks) and the role of expression of the different nitric oxide synthase isoforms. Bile duct ligation led to an important accumulation of collagen in the hepatic parenchyma, as shown both histologically and by the hydroxyproline contents of livers. Bilirubin and serum enzyme activities (measured as markers of cholestasis) increased several-fold after bile duct ligation. The area of fibrotic tissue, liver hydroxyproline content and serum markers of cholestasis were clearly related in obstructed rats. The absence of modifications in haemodynamic parameters excludes circulatory changes from being responsible for the development of liver alterations. In animals treated with NG-nitro-L-arginine methyl ester (L-NAME) the area of fibrosis was similar to that of untreated animals, the signs of cholestasis and cellular injury being more evident. In rats treated with L-arginine the area of fibrosis was almost three times larger than that found in bile duct ligated rats and in L-NAME-treated bile duct ligated rats, although the observed biochemical changes were similar to those seen in rats treated with L-NAME. Our results with inducible nitric oxide synthase, obtained by Western blots and immunohistochemistry, indicate a greater expression of the inducible enzyme in bile duct ligated and L-arginine-treated animals and a lower expression in the L-NAME and control groups. Constitutive nitric oxide synthase expression, obtained by Western blots, was very similar in all groups, except for the L-arginine-treated rats in which it was lower. These results suggest that nitric oxide production may be a key factor in the development of fibrosis in bile duct ligated rats. They also support the hypothesis of a dual role for nitric oxide; one beneficial, mediated by its circulatory effects, and the second negative, through its local toxic effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10029566

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  10 in total

1.  Hepatic damage in biliary-obstructed rats is ameliorated by leflunomide treatment.

Authors:  Abdurrahman Karaman; Mustafa Iraz; Hale Kirimlioglu; Nese Karadag; Erkan Tas; Ersin Fadillioglu
Journal:  Pediatr Surg Int       Date:  2006-08-05       Impact factor: 1.827

2.  Role of prostanoids and nitric oxide inhibition in rats with experimental hepatic fibrosis.

Authors:  M Criado; O Flores; M J Vázquez; A Esteller
Journal:  J Physiol Biochem       Date:  2000-09       Impact factor: 4.158

3.  The role of iNOS in cholesterol-induced liver fibrosis.

Authors:  Sarit Anavi; Michal Eisenberg-Bord; Michal Hahn-Obercyger; Olga Genin; Mark Pines; Oren Tirosh
Journal:  Lab Invest       Date:  2015-06-22       Impact factor: 5.662

4.  Effect of leflunomide on liver regeneration after partial hepatectomy in rats.

Authors:  Abdurrahman Karaman; Hale Kirimlioglu; Erkan Tas; Nese Karadag; Cebrail Gülsul; Ersin Fadillioglu; Mehmet Demircan
Journal:  Pediatr Surg Int       Date:  2010-02       Impact factor: 1.827

5.  Taurine attenuates radiation-induced lung fibrosis in C57/Bl6 fibrosis prone mice.

Authors:  W B Robb; C Condron; M Moriarty; T N Walsh; D J Bouchier-Hayes
Journal:  Ir J Med Sci       Date:  2009-07-16       Impact factor: 1.568

6.  Telmisartan plus propranolol improves liver fibrosis and bile duct proliferation in the PSC-like Abcb4-/- mouse model.

Authors:  Susanne Mende; Sigrid Schulte; Ingo Strack; Heike Hunt; Margarete Odenthal; Galyna Pryymachuck; Maria Quasdorff; Münevver Demir; Dirk Nierhoff; Hans-Peter Dienes; Tobias Goeser; Hans-Michael Steffen; Ulrich Töx
Journal:  Dig Dis Sci       Date:  2012-12-18       Impact factor: 3.199

7.  Effects of quercetin on liver damage in rats with carbon tetrachloride-induced cirrhosis.

Authors:  Amalia Pavanato; María J Tuñón; Sonia Sánchez-Campos; Claudio A Marroni; Susana Llesuy; Javier González-Gallego; Norma Marroni
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

8.  Can Chronic Nitric Oxide Inhibition Improve Liver and Renal Dysfunction in Bile Duct Ligated Rats?

Authors:  Mona Fouad Mahmoud; Sara Zakaria; Ahmed Fahmy
Journal:  Adv Pharmacol Sci       Date:  2015-11-25

9.  The Role of e-NOS in Chronic Cholestasis-Induced Liver and Renal Injury in Rats: The Effect of N-Acetyl Cysteine.

Authors:  Yusuf Gunay; Semsi Altaner; Nergiz Ekmen
Journal:  Gastroenterol Res Pract       Date:  2014-11-09       Impact factor: 2.260

10.  Possible Involvement of Nitric Oxide in Enhanced Liver Injury and Fibrogenesis during Cholestasis in Cytoglobin-deficient Mice.

Authors:  Tuong Thi Van Thuy; Le Thi Thanh Thuy; Katsutoshi Yoshizato; Norifumi Kawada
Journal:  Sci Rep       Date:  2017-02-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.